BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20084527)

  • 1. The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity.
    Takino J; Kobayashi Y; Takeuchi M
    J Gastroenterol; 2010 Jun; 45(6):646-55. PubMed ID: 20084527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression.
    Takino J; Yamagishi S; Takeuchi M
    World J Gastroenterol; 2012 Apr; 18(15):1781-8. PubMed ID: 22553402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro identification of nonalcoholic fatty liver disease-related protein hnRNPM.
    Takino J; Nagamine K; Takeuchi M; Hori T
    World J Gastroenterol; 2015 Feb; 21(6):1784-93. PubMed ID: 25684943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of glyceraldehyde-derived advanced glycation end-products in pancreatic cancer cells and the potential of tumor promotion.
    Takata T; Ueda T; Sakasai-Sakai A; Takeuchi M
    World J Gastroenterol; 2017 Jul; 23(27):4910-4919. PubMed ID: 28785145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death.
    Sakasai-Sakai A; Takata T; Takino JI; Takeuchi M
    Sci Rep; 2017 Oct; 7(1):14282. PubMed ID: 29079763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells.
    Iwamoto K; Kanno K; Hyogo H; Yamagishi S; Takeuchi M; Tazuma S; Chayama K
    J Gastroenterol; 2008; 43(4):298-304. PubMed ID: 18458846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyceraldehyde-Derived Pyridinium Evokes Renal Tubular Cell Damage via RAGE Interaction.
    Sotokawauchi A; Nakamura N; Matsui T; Higashimoto Y; Yamagishi SI
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.
    Takeuchi M; Yamagishi S
    Curr Pharm Des; 2008; 14(10):973-8. PubMed ID: 18473848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients.
    Mao Z; Baker JR; Takeuchi M; Hyogo H; Tjønneland A; Eriksen AK; Severi G; Rothwell J; Laouali N; Katzke V; Kaaks R; Schulze MB; Palli D; Sieri S; de Magistris MS; Tumino R; Sacerdote C; Derksen JWG; Gram IT; Skeie G; Sandanger TM; Quirós JR; Crous-Bou M; Sánchez MJ; Amiano P; Colorado-Yohar SM; Guevara M; Harlid S; Johansson I; Perez-Cornago A; Freisling H; Gunter M; Weiderpass E; Heath AK; Aglago E; Jenab M; Fedirko V
    Int J Cancer; 2023 Jun; 152(11):2257-2268. PubMed ID: 36715363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells.
    Sakasai-Sakai A; Takata T; Takeuchi M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32660150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of glyceraldehyde-derived advanced glycation end-products in the liver of insulin-resistant mice.
    Ebata Y; Takino J; Tsuchiya H; Sakabe T; Ikeda Y; Hama S; Kogure K; Takeuchi M; Shiota G
    Int J Vitam Nutr Res; 2013; 83(2):137-41. PubMed ID: 24491887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MK615 decreases RAGE expression and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells.
    Sakuraoka Y; Sawada T; Okada T; Shiraki T; Miura Y; Hiraishi K; Ohsawa T; Adachi M; Takino J; Takeuchi M; Kubota K
    World J Gastroenterol; 2010 Nov; 16(42):5334-41. PubMed ID: 21072897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products impair glucose-induced insulin secretion from rat pancreatic β-cells.
    Hachiya H; Miura Y; Inoue K; Park KH; Takeuchi M; Kubota K
    J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):134-41. PubMed ID: 23798335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glyceraldehyde-derived advanced glycation end products in Alzheimer's disease.
    Choei H; Sasaki N; Takeuchi M; Yoshida T; Ukai W; Yamagishi S; Kikuchi S; Saito T
    Acta Neuropathol; 2004 Sep; 108(3):189-93. PubMed ID: 15221334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chebulic acid prevents hepatic fibrosis induced by advanced glycation end-products in LX-2 cell by modulating Nrf2 translocation via ERK pathway.
    Koo YC; Pyo MC; Nam MH; Hong CO; Yang SY; Lee KW
    Toxicol In Vitro; 2016 Aug; 34():8-15. PubMed ID: 27021876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a monoclonal antibody-based ELISA system for glyceraldehyde-derived advanced glycation end products.
    Matsui T; Joo HD; Lee JM; Ju SM; Tao WH; Higashimoto Y; Fukami K; Yamagishi S
    Immunol Lett; 2015 Oct; 167(2):141-6. PubMed ID: 26304702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia.
    Takeda M; Ohnuma T; Takeuchi M; Katsuta N; Maeshima H; Takebayashi Y; Higa M; Nakamura T; Nishimon S; Sannohe T; Hotta Y; Hanzawa R; Higashiyama R; Shibata N; Gohda T; Suzuki Y; Yamagishi S; Tomino Y; Arai H
    Neurosci Lett; 2015 Apr; 593():51-5. PubMed ID: 25766756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glyceraldehyde-derived advanced glycation end-products are associated with left ventricular ejection fraction and brain natriuretic peptide in patients with diabetic adverse cardiac remodeling.
    Yasuda Y; Aoki H; Fujita W; Fujibayashi K; Wakasa M; Kawai Y; Nakanishi H; Saito K; Takeuchi M; Kajinami K
    Scand Cardiovasc J; 2022 Dec; 56(1):208-216. PubMed ID: 35792728
    [No Abstract]   [Full Text] [Related]  

  • 19. The specific localization of advanced glycation end-products (AGEs) in rat pancreatic islets.
    Morioka Y; Teshigawara K; Tomono Y; Wang D; Izushi Y; Wake H; Liu K; Takahashi HK; Mori S; Nishibori M
    J Pharmacol Sci; 2017 Aug; 134(4):218-224. PubMed ID: 28843667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-products.
    Takino J; Yamagishi S; Takeuchi M
    J Oncol; 2010; 2010():739852. PubMed ID: 20631911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.